相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
Rie Hamano et al.
CLINICAL CANCER RESEARCH (2011)
The expression of the miRNA-200 family in endometrial endometrioid carcinoma
Jeong-Won Lee et al.
GYNECOLOGIC ONCOLOGY (2011)
Single-Nucleotide Polymorphisms Inside MicroRNA Target Sites Influence Tumor Susceptibility
Milena S. Nicoloso et al.
CANCER RESEARCH (2010)
Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2α overexpression
N. Jonckheere et al.
BRITISH JOURNAL OF CANCER (2009)
A Risk Variant in an miR-125b Binding Site in BMPR1B Is Associated with Breast Cancer Pathogenesis
Pal Saetrom et al.
CANCER RESEARCH (2009)
DIANA-microT web server: elucidating microRNA functions through target prediction
M. Maragkakis et al.
NUCLEIC ACIDS RESEARCH (2009)
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine
Prasun J. Mishra et al.
PHARMACOGENOMICS (2009)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The AP-2α transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene
Hee-Jung Choi et al.
GLYCOBIOLOGY (2008)
Transcription factor AP-2α represses both the mucin MUC4 expression and pancreatic cancer cell proliferation
Valerie Fauquette et al.
CARCINOGENESIS (2007)
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance
Prasun J. Mishra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss of AP-2α results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo
B. Schwartz et al.
ONCOGENE (2007)
Apoptosis induction by activator protein 2α involves transcriptional repression of Bcl-2
Narendra Wajapeyee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Activator protein 2α status determines the chemosensitivity of cancer cells:: Implications in cancer chemotherapy
N Wajapeyee et al.
CANCER RESEARCH (2005)
Genomic organization, promoter characterization and roles of Sp1 and AP-2 in the basal transcription of mouse PDIP1 gene
JL Zhou et al.
FEBS LETTERS (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
The AP-2 family of transcription factors
Dawid Eckert et al.
GENOME BIOLOGY (2005)
Activator protein 2α inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells
M Ruiz et al.
CANCER RESEARCH (2004)
Cell cycle arrest and apoptosis induction by activator protein 2α (AP-2α) and the role of p53 and p21WAF1/CIP1 in AP-2α-mediated growth inhibition
N Wajapeyee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Requirement for AP-2 alpha in cardiac outflow tract morphogenesis
S Brewer et al.
MECHANISMS OF DEVELOPMENT (2002)
分享论文
